Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline for Apathy in Drug-naïve Parkinson's Disease
NCT01765257Phase 4Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2013
- Primary completion
- Dec 2014
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of rasagiline in apathy, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
rasagiline
03
Conditions
apathy
Beyond the preview
Go deeper on NCT01765257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01765257.